HomeMy WebLinkAboutKyocera Black TonerPage 1
SAFETY DATA SHEET
Section 1. Chemical Product and Company Identification
Product Name Black Toner For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci
Manufacturer KYOCERA Document Solutions Inc.
Address KYOCERA Document Solutions America, Inc.
225 Sand Road
Fairfield, NJ 07004
Telephone Number (973)-808-8444
Date April 01, 2015
Section 2. Composition/Information on Ingredients
Hazardous Components
(Chemical Identity, Common Name/s )SubpartZ ACGIH TLV IARC NTP Weight%
(CAS No. 1333-86-4)Carbon Black 3.5mg/m3(TWA)Group2B Not Listed 5-10
(CAS No. 66402-68-4)Ferrite (Ferrite including manganese)0.2mg/m3**Not Listed Not Listed 1-10***
(CAS No. 7631-86-9)Amorphous silica Not Listed Group3 Not Listed 1-5
(CAS No. 13463-67-7)Titanium dioxide 10mg/m3(TWA)Group 2B Not Listed <1
(Non Hazardous Ingredients)
Polyester resin 65-75
*(Ceiling)(Manganese compounds(asMn))
**(TWA)(Manganese and inorganic compounds as Mn)
***(as Mn:<2)
Section 3. Hazards Identification
Most Important Hazards None
Specific Hazards None
Other Information on Hazards: Potential Health Effects:
Ingestion Ingestion is not applicable route of entry for intended use.
Inhalation Prolonged inhalation of excessive dusts may cause lung damage.
Use of this product, as intended, does not result in inhalation of excessive dusts.
Eye Contact May cause transient eye irritation.
Skin Contact Unlikely to cause skin irritation.
3.5mg/m3 (TWA)
OSHA PEL
80mg/m3/%SiO2(TWA)
5mg/m3*
15mg/m3
Black Toner For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 2 of 4 4/01/2015
SAFETY DATA SHEET
Section 4. First Aid Measures
Inhalation Remove from exposure to fresh air and gargle with plenty of water.
Seek medical treatment in case of such a symptom as coughing.
Skin Contact Wash with soap and water. If irritation does occur, seek medical treatment.
Eye Contact Flush thoroughly with water and seek medical treatment if irritating.
Ingestion Ingestion is not applicable route of entry for intended use.
Rinse out mouth. Drink one or two glasses of water to dilute.
Seek medical treatment if necessary.
Section 5. Fire Fighting Measures
Extinguishing Media Water (Sprinkle with water), Foam, Powder, CO2 or Dry Chemical Extinguisher.
Fire Fighting Procedure Pay attention not to blow away toner powder. Drain water off around and decrease
the atmosphere temperature to extinguish the fire.
Section 6. Accidental Release Measures
Personal Precautions Avoid inhalation, ingestion, eye and skin contact in case of accidental toner release.
Environmental Precautions Do not release into drains and surface water.
Method for Cleaning Up Gather the released toner, not blowing away, and wipe up with a wet cloth.
Section 7. Handling and Storage
Handling Keep the container tightly closed.
Keep away from children.
Storage Keep the container tightly closed and store in a cool, dry and dark place keeping
away from fire. Keep away from children.
Section 8. Exposure Controls/Personal Protection
Control Parameters<Reference Data>
ACGIH TLV(2)-TWA Inhalable fraction 10mg/m3, Respirable fraction 3mg/m3
OSHA PEL(3)-TWA Total dust 15mg/m3, Respirable fraction 5mg/m3
Protective Equipment
Respiratory Protection None required under normal use.
Eye/Face Protection None required under normal use.
Skin/Hand/Body Protection None required under normal use.
Ventilation Ventilator is not required under normal use.
Black Toner For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 3 of 4 4/01/2015
SAFETY DATA SHEET
Section 9. Physical and Chemical Properties
Appearance Physical state Solid Form Fine powder Color Black Odor Odorless
pH Not applicable
Melting Point 100-1200C[Toner]
Explosion Properties Dust explosion is improbable under normal use. Experimental explosiveness of toneris classified into the same rank such kind of powder as flour, dry milk and resin powderaccording to the pressure rising speed.
Density 1.2-1.4g/cm3[Toner]
Solubility Almost insoluble in water.
Section 10. Stability and Reactivity
Stability/Reactivity Stable under normal use.
Hazardous Decomposition Products None
Section 11. Toxicological Information
Acute oral toxicity (rat)LD50>2,000mg/kg (Estimated from other products containing same materials.)[Toner]
(rat)LD50>2,500mg/kg (Estimated from the data of constituent materials.)[Carrier]
Acute dermal toxicity (rat)LD50>2,000mg/kg (Estimated from Acute oral toxicity for same product.)[Toner]
(rat)LD50>2,000mg/kg (Estimated from the data of constituent materials.)[Carrier]
Acute inhalation toxicity (rat)LC50(4hr)>5.0mg/l (Estimated from other products containing same materials.)[Toner]
Acute eye irritation (rabbit) Minimal irritant (Estimated from other products containing same materials.)[Toner]
Acute skin irritation (rabbit) Non-irritant (Estimated from other products containing same materials.)[Toner]
(rabbit) Non-irritant (Estimated from the data of constituent materials.)[Carrier]
Skin sensitization (mouse)Non-Sensitiser (Estimated from other products containing same materials.)[Toner]
(guinea pig)Non-Sensitiser (Estimated from the data of constituent materials.)[Carrier]
Mutagenicity Ames Test is Negative.[Toner]
Ames Test is Negative. (Estimated from the data of constituent materials.)[Carrier]
Information of Ingredients: No mutagen, according to MAK, TRGS905 and (EC)No 1272/2008
AnnexVI Table3.2.
Reproductive Toxicity
Information of Ingredients: No reproductive toxicant, according to MAK, California Proposition 65, TRGS905 and (EC)No 1272/2008
AnnexVI Table3.2.
Carcinogenicity
Information of Ingredients: No carcinogen or potential carcinogen (except carbon black and titanium dioxide) according to IARC,
Japan Association on Industrial Health, ACGIH, EPA, OSHA, NTP, MAK, California Proposition 65,
TRGS 905, and (EC)No 1272/2008 AnnexVI Table3.2.
The IARC reevaluated carbon black and titanium dioxide as a Group 2B carcinogen (possibly carcinogenic to humans) as the result of inhalation exposure tests in rats. But, oral/skin test does not show carcinogenicity. (4) The evaluation of carbon black is based upon the development of lung tumors in rat receiving chronic inhalation
exposures to free carbon black at level that induce particle overload of the lung.
The studies performed in animal models other than rats have not demonstrated an association between carbon black and lung tumors. Moreover, a two-years cancer bioassay using a typical toner preparation containing carbon black demonstrated no association between toner exposure and tumor development in rats.(1)
In the animal chronic inhalation studies for titanium dioxide, the lung tumor was observed in only rats. It is estimated that this is attributed to the overload of rat'slung clearance mechanism (overload phenomenon).(5) The inhalation of excessive titanium dioxide does not occur in normal use of this product. Also,
epidemiological studies to date have not revealed any evidence of the relation between occupational exposure to titanium dioxide and respiratory tract diseases.
Chronic effects:
In a study in rats by chronic inhalation exposure to a typical toner, a mild to moderate degree of lung fibrosis was observed in 92% of the rats in the high concentration(16mg/m3) exposure group, and a minimal to mild degree of fibrosis was noted in 22% of the animal in the middle (4mg/m3) exposure group.(1) But no pulmonary change was reported in the lowest (1mg/m3) exposure group, the most relevant level to potential human exposures.
Other Information: None
Black Toner For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 4 of 4 4/01/2015
SAFETY DATA SHEET
Section 12. Ecological Information
No data available.
Section 13. Disposal Considerations
Do not incinerate toner and toner containers. Dangerous sparks may cause burn.
Any disposal practice should be done under conditions which meet local, state and federal laws
and regulations relating to waste (contact local or state environmental agency for specific rules).
Section 14. Transport Information
UN No.None
UN Shipping Name None
UN Classification None
UN Packing Group None
Special Precautions None
Section 15. Regulatory Information
US Information
All components in this product comply with order under TSCA.
EU Information Label information according to the Directives 67/548/EEC and 1999/45/EC
Symbol & Indication Not required
R-Phrase Not required
S-Phrase Not required
Special markings Not required
Hazardous ingredients for labeling None
Canada Information
This product is not a WHMIS-controlled product, since we consider it as a Manufactured article.
Section 16. Other Information
To the best of our knowledge, the information contained herein is accurate. However, we cannot assume any liability
whatsoever for the accuracy or completeness of the information contained herein.
<Reference>
(1) Pulmonary Response to Toner upon Chronic Inhalation Exposure in Rats H. Muhle et. al Fundamental and Applied Toxicology 17.280-299(1991)
Lung Clearance and Retention of Toner, Utilizing a Tracer Technique, during Chronic Inhalation Exposure in Rats B Bellmann Fundamental and Applied Toxicology 17.300-313(19
(2) ACGIH TLV (Threshold Limit Values)
(3) OSHA PEL (Permissible Exposure Limits)
(4) IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol.93.
(5) NIOSH CURRENT INTELLIGENCE BULLETIN "Evaluation of Health Hazard and Recommendation for Occupational Exposure to Titanium Dioxide DRAFT".
*ISO 11014-1 Safety data sheet for chemical products.
<Abbreviation>
ACGIH American Conference of Governmental Industrial Hygienists
OSHA Occupational Safety and Health Administration
TWA Time Weighted Average
IARC International Agency for Research on Cancer
EPA Environmental Protection Agency (USA)
NTP National Toxicology Program
MAK Maximale Arbeitsplatzkonzentrationen under Deutsche Forschungsgemeinschaft
Proposition 65:California Safe Drinking Water and Toxic Enforcement Act of 1986.
TRGS905 Technische Regeln für Gefahrstoffe (Deutsche)
UN United Nations
TSCA Toxic Substances Control Act (USA)
WHMIS Workplace Hazardous Materials Information System(Canada)
End of MSDS
Page 1
SAFETY DATA SHEET
Section 1. Chemical Product and Company Identification
Product Name Cyan Toner For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci
Manufacturer KYOCERA Document Solutions Inc.
Address KYOCERA Document Solutions America, Inc.
225 Sand Road
Fairfield, NJ 07004
Telephone Number (973)-808-8444
Date April 01, 2015
Section 2. Composition/Information on Ingredients
Hazardous Components
(Chemical Identity, Common Name/s )SubpartZ ACGIH TLV IARC NTP Weight%
(CAS No. 66402-68-4)Ferrite (Ferrite including manganese)0.2mg/m3**Not Listed Not Listed 1-10***
(CAS No. 7631-86-9)Amorphous silica Not Listed Group3 Not Listed 1-5
(CAS No. 13463-67-7)Titanium dioxide 10mg/m3(TWA)Group 2B Not Listed <1
(Non Hazardous Ingredients)
Polyester resin (2 kinds)70-85
*(Ceiling)(Manganese compounds(asMn))
**(TWA)(Manganese and inorganic compounds as Mn)
***(as Mn:<2)
Section 3. Hazards Identification
Most Important Hazards None
Specific Hazards None
Other Information on Hazards: Potential Health Effects:
Ingestion Ingestion is not applicable route of entry for intended use.
Inhalation Prolonged inhalation of excessive dusts may cause lung damage.
Use of this product, as intended, does not result in inhalation of excessive dusts.
Eye Contact May cause transient eye irritation.
Skin Contact Unlikely to cause skin irritation.
OSHA PEL
80mg/m3/%SiO2(TWA)
5mg/m3*
15mg/m3
Cyan Toner For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 2 of 4 4/01/2015
SAFETY DATA SHEET
Section 4. First Aid Measures
Inhalation Remove from exposure to fresh air and gargle with plenty of water.
Seek medical treatment in case of such a symptom as coughing.
Skin Contact Wash with soap and water. If irritation does occur, seek medical treatment.
Eye Contact Flush thoroughly with water and seek medical treatment if irritating.
Ingestion Ingestion is not applicable route of entry for intended use.
Rinse out mouth. Drink one or two glasses of water to dilute.
Seek medical treatment if necessary.
Section 5. Fire Fighting Measures
Extinguishing Media Water (Sprinkle with water), Foam, Powder, CO2 or Dry Chemical Extinguisher.
Fire Fighting Procedure Pay attention not to blow away toner powder. Drain water off around and decrease
the atmosphere temperature to extinguish the fire.
Section 6. Accidental Release Measures
Personal Precautions Avoid inhalation, ingestion, eye and skin contact in case of accidental toner release.
Environmental Precautions Do not release into drains and surface water.
Method for Cleaning Up Gather the released toner, not blowing away, and wipe up with a wet cloth.
Section 7. Handling and Storage
Handling Keep the container tightly closed.
Keep away from children.
Storage Keep the container tightly closed and store in a cool, dry and dark place keeping
away from fire. Keep away from children.
Section 8. Exposure Controls/Personal Protection
Control Parameters<Reference Data>
ACGIH TLV(2)-TWA Inhalable fraction 10mg/m3, Respirable fraction 3mg/m3
OSHA PEL(3)-TWA Total dust 15mg/m3, Respirable fraction 5mg/m3
Protective Equipment
Respiratory Protection None required under normal use.
Eye/Face Protection None required under normal use.
Skin/Hand/Body Protection None required under normal use.
Ventilation Ventilator is not required under normal use.
Cyan Toner For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 3 of 4 4/01/2015
SAFETY DATA SHEET
Section 9. Physical and Chemical Properties
Appearance
Physical state Solid
Form Fine powder
Color Cyan
Odor Odorless
pH Not applicable
Melting Point 100-1200C[Toner]
Explosion Properties Dust explosion is improbable under normal use. Experimental explosiveness of toner
is classified into the same rank such kind of powder as flour, dry milk and resin powder
according to the pressure rising speed.
Density 1.2-1.4g/cm3[Toner]
Solubility Almost insoluble in water.
Section 10. Stability and Reactivity
Stability/Reactivity Stable under normal use.
Hazardous Decomposition Products None
Section 11. Toxicological Information
Acute oral toxicity (rat)LD50>2,000mg/kg (Estimated from other products containing same materials.)[Toner]
(rat)LD50>2,500mg/kg (Estimated from the data of constituent materials.)[Carrier]
Acute dermal toxicity (rat)LD50>2,000mg/kg (Estimated from Acute oral toxicity for same product.)[Toner]
(rat)LD50>2,000mg/kg (Estimated from the data of constituent materials.)[Carrier]
Acute inhalation toxicity (rat)LC50(4hr)>5.0mg/l (Estimated from other products containing same materials.)[Toner]
Acute eye irritation (rabbit) Minimal irritant (Estimated from other products containing same materials.)[Toner]
Acute skin irritation (rabbit) Non-irritant (Estimated from other products containing same materials.)[Toner]
(rabbit) Non-irritant (Estimated from the data of constituent materials.)[Carrier]
Skin sensitization (mouse)Non-Sensitiser (Estimated from other products containing same materials.)[Toner](guinea pig)Non-Sensitiser (Estimated from the data of constituent materials.)[Carrier]
Mutagenicity Ames Test is Negative.[Toner]
Ames Test is Negative. (Estimated from the data of constituent materials.)[Carrier]
Information of Ingredients: No mutagen, according to MAK, TRGS905 and (EC)No 1272/2008
AnnexVI Table3.2.
Reproductive Toxicity
Information of Ingredients: No reproductive toxicant, according to MAK, California Proposition 65, TRGS905 and (EC)No 1272/2008
AnnexVI Table3.2.
Carcinogenicity
Information of Ingredients: No carcinogen or potential carcinogen (except titanium dioxide) according to IARC, Japan Association
on Industrial Health, ACGIH, EPA, OSHA, NTP, MAK, California Proposition 65, TRGS905, and (EC)
No 1272/2008 AnnexVI Table3.2.
The IARC reevaluated titanium dioxide as a Group 2B carcinogen (possibly carcinogenic to humans) as the result of inhalation exposure test in rats. But, oral/skin test does not show carcinogenicity. (4) In the animal chronic inhalation studies for titanium dioxide, the lung
tumor was observed in only rats. It is estimated that this is attributed to the overload of the rat's lung clearance mechanism (overload phenomenon).(5)
The inhalation of excessive titanium dioxide does not occur in normal use of this product. Also, epidemiological studies to date have not revealed any evidence of the relation between occupational exposure to titanium dioxide and respiratory tract diseases.
Chronic effects: In a study in rats by chronic inhalation exposure to a typical toner, a mild to moderate degree of lung fibrosis was observed in 92% of the rats
in the high concentration (16mg/m3) exposure group, and a minimal to mild degree of fibrosis was noted in 22% of the animal in the middle
(4mg/m3) exposure group.(1) But no pulmonary change was reported in the lowest (1mg/m3) exposure group, the most relevant level to
potential human exposures.
Other Information: None
Cyan Toner For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 4 of 4 4/01/2015
SAFETY DATA SHEET
Section 12. Ecological Information
No data available.
Section 13. Disposal Considerations
Do not incinerate toner and toner containers. Dangerous sparks may cause burn.Any disposal practice should be done under conditions which meet local, state and federal lawsand regulations relating to waste (contact local or state environmental agency for specific rules).
Section 14. Transport Information
UN No.NoneUN Shipping Name NoneUN Classification NoneUN Packing Group NoneSpecial Precautions None
Section 15. Regulatory Information
US Information
All components in this product comply with order under TSCA.
EU Information Label information according to the Directives 67/548/EEC and 1999/45/EC) Symbol & Indication Not required
R-Phrase Not required S-Phrase Not required Special markings Not required Hazardous ingredients for labeling None
Canada Information
This product is not a WHMIS-controlled product, since we consider it as a Manufactured article.
Section 16. Other Information
To the best of our knowledge, the information contained herein is accurate. However, we cannot assume any liability
whatsoever for the accuracy or completeness of the information contained herein.
<Reference>
(1) Pulmonary Response to Toner upon Chronic Inhalation Exposure in Rats H. Muhle et. al Fundamental and Applied Toxicology 17.280-299(1991)
Lung Clearance and Retention of Toner, Utilizing a Tracer Technique, during Chronic Inhalation Exposure in Rats B Bellmann Fundamental and Applied Toxicology 17.300-313(199
(2) ACGIH TLV (Threshold Limit Values)
(3) OSHA PEL (Permissible Exposure Limits)
(4) IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol.93.
(5) NIOSH CURRENT INTELLIGENCE BULLETIN "Evaluation of Health Hazard and Recommendation for Occupational Exposure to Titanium Dioxide DRAFT".
*ISO 11014-1 Safety data sheet for chemical products.
<Abbreviation> ACGIH American Conference of Governmental Industrial Hygienists OSHA Occupational Safety and Health Administration TWA Time Weighted Average IARC International Agency for Research on Cancer EPA Environmental Protection Agency (USA) NTP National Toxicology Program MAK Maximale Arbeitsplatzkonzentrationen under Deutsche Forschungsgemeinschaft PEL Permissible Exposure Limit Proposition 65:California Safe Drinking Water and Toxic Enforcement Act of 1986. TRGS905 Technische Regeln für Gefahrstoffe (Deutsche) UN United Nations TSCA Toxic Substances Control Act (USA) WHMIS Workplace Hazardous Materials Information System(Canada)
End of MSDS
Page 1
SAFETY DATA SHEET
Section 1. Chemical Product and Company Identification
Product Name Magenta Toner For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci
Manufacturer KYOCERA Document Solutions Inc.
Address KYOCERA Document Solutions America, Inc.
225 Sand Road
Fairfield, NJ 07004
Telephone Number (973)-808-8444
Date April 01, 2015
Section 2. Composition/Information on Ingredients
Hazardous Components
(Chemical Identity, Common Name/s )SubpartZ ACGIH TLV IARC NTP Weight%
(CAS No. 66402-68-4)Ferrite (Ferrite including manganese)0.2mg/m3**Not Listed Not Listed 1-10***
(CAS No. 7631-86-9)Amorphous silica Not Listed Group3 Not Listed 1-5
(CAS No. 13463-67-7)Titanium dioxide 10mg/m3(TWA)Group 2B Not Listed <1
(Non Hazardous Ingredients)
Polyester resin (2 kinds)70-85
*(Ceiling)(Manganese compounds(asMn))
**(TWA)(Manganese and inorganic compounds as Mn)
***(as Mn:<2)
Section 3. Hazards Identification
Most Important Hazards None
Specific Hazards None
Other Information on Hazards: Potential Health Effects:
Ingestion Ingestion is not applicable route of entry for intended use.
Inhalation Prolonged inhalation of excessive dusts may cause lung damage.
Use of this product, as intended, does not result in inhalation of excessive dusts.
Eye Contact May cause transient eye irritation.
Skin Contact Unlikely to cause skin irritation.
OSHA PEL
80mg/m3/%SiO2(TWA)
5mg/m3*
15mg/m3
Magenta Toner For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 2 of 4 4/01/2015
SAFETY DATA SHEET
Section 4. First Aid Measures
Inhalation Remove from exposure to fresh air and gargle with plenty of water.
Seek medical treatment in case of such a symptom as coughing.
Skin Contact Wash with soap and water. If irritation does occur, seek medical treatment.
Eye Contact Flush thoroughly with water and seek medical treatment if irritating.
Ingestion Ingestion is not applicable route of entry for intended use.
Rinse out mouth. Drink one or two glasses of water to dilute.
Seek medical treatment if necessary.
Section 5. Fire Fighting Measures
Extinguishing Media Water (Sprinkle with water), Foam, Powder, CO2 or Dry Chemical Extinguisher.
Fire Fighting Procedure Pay attention not to blow away toner powder. Drain water off around and decrease
the atmosphere temperature to extinguish the fire.
Section 6. Accidental Release Measures
Personal Precautions Avoid inhalation, ingestion, eye and skin contact in case of accidental toner release.
Environmental Precautions Do not release into drains and surface water.
Method for Cleaning Up Gather the released toner, not blowing away, and wipe up with a wet cloth.
Section 7. Handling and Storage
Handling Keep the container tightly closed.
Keep away from children.
Storage Keep the container tightly closed and store in a cool, dry and dark place keeping
away from fire. Keep away from children.
Section 8. Exposure Controls/Personal Protection
Control Parameters<Reference Data>
ACGIH TLV(2)-TWA Inhalable fraction 10mg/m3, Respirable fraction 3mg/m3
OSHA PEL(3)-TWA Total dust 15mg/m3, Respirable fraction 5mg/m3
Protective Equipment
Respiratory Protection None required under normal use.
Eye/Face Protection None required under normal use.
Skin/Hand/Body Protection None required under normal use.
Ventilation Ventilator is not required under normal use.
Magenta Toner For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 3 of 4 4/01/2015
SAFETY DATA SHEET
Section 9. Physical and Chemical Properties
Appearance
Physical state Solid
Form Fine powder
Color Magenta
Odor Odorless
pH Not applicable
Melting Point 100-1200C[Toner]
Explosion Properties Dust explosion is improbable under normal use. Experimental explosiveness of toner
is classified into the same rank such kind of powder as flour, dry milk and resin powder
according to the pressure rising speed.
Density 1.2-1.4g/cm3[Toner]
Solubility Almost insoluble in water.
Section 10. Stability and Reactivity
Stability/Reactivity Stable under normal use.
Hazardous Decomposition Products None
Section 11. Toxicological Information
Acute oral toxicity (rat)LD50>2,000mg/kg (Estimated from other products containing same materials.)[Toner]
(rat)LD50>2,500mg/kg (Estimated from the data of constituent materials.)[Carrier]
Acute dermal toxicity (rat)LD50>2,000mg/kg (Estimated from Acute oral toxicity for same product.)[Toner]
(rat)LD50>2,000mg/kg (Estimated from the data of constituent materials.)[Carrier]
Acute inhalation toxicity (rat)LC50(4hr)>5.0mg/l (Estimated from other products containing same materials.)[Toner]
Acute eye irritation (rabbit) Minimal irritant (Estimated from other products containing same materials.)[Toner]
Acute skin irritation (rabbit) Non-irritant (Estimated from other products containing same materials.)[Toner]
(rabbit) Non-irritant (Estimated from the data of constituent materials.)[Carrier]
Skin sensitization (mouse)Non-Sensitiser (Estimated from other products containing same materials.)[Toner]
(guinea pig)Non-Sensitiser (Estimated from the data of constituent materials.)[Carrier]
Mutagenicity Ames Test is Negative.[Toner]
Ames Test is Negative. (Estimated from the data of constituent materials.)[Carrier]
Information of Ingredients: No mutagen, according to MAK, TRGS905 and (EC)No 1272/2008
AnnexVI Table3.2.
Reproductive Toxicity
Information of Ingredients: No reproductive toxicant, according to MAK, California Proposition 65, TRGS905 and (EC)No 1272/2008
AnnexVI Table3.2.
Carcinogenicity
Information of Ingredients: No carcinogen or potential carcinogen (except titanium dioxide) according to IARC, Japan Association
on Industrial Health, ACGIH, EPA, OSHA, NTP, MAK, California Proposition 65, TRGS905, and (EC)
No 1272/2008 AnnexVI Table3.2.
The IARC reevaluated titanium dioxide as a Group 2B carcinogen (possibly carcinogenic to humans) as the result of inhalation exposure
test in rats. But, oral/skin test does not show carcinogenicity. (4) In the animal chronic inhalation studies for titanium dioxide, the lung
tumor was observed in only rats. It is estimated that this is attributed to the overload of the rat's lung clearance mechanism (overload
phenomenon).(5)
The inhalation of excessive titanium dioxide does not occur in normal use of this product. Also, epidemiological studies to date have not revealed any evidence of the relation between occupational exposure to titanium dioxide and respiratory tract diseases.
Chronic effects: In a study in rats by chronic inhalation exposure to a typical toner, a mild to moderate degree of lung fibrosis was observed in 92% of the rats
in the high concentration (16mg/m3) exposure group, and a minimal to mild degree of fibrosis was noted in 22% of the animal in the middle
(4mg/m3) exposure group.(1) But no pulmonary change was reported in the lowest (1mg/m3) exposure group, the most relevant level to
potential human exposures.
Other Information: None
Magenta Toner For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 4 of 4 4/01/2015
SAFETY DATA SHEET
Section 12. Ecological Information
No data available.
Section 13. Disposal Considerations
Do not incinerate toner and toner containers. Dangerous sparks may cause burn.Any disposal practice should be done under conditions which meet local, state and federal lawsand regulations relating to waste (contact local or state environmental agency for specific rules).
Section 14. Transport Information
UN No.NoneUN Shipping Name NoneUN Classification NoneUN Packing Group NoneSpecial Precautions None
Section 15. Regulatory Information
US Information
All components in this product comply with order under TSCA.
EU Information Label information according to the Directives 67/548/EEC and 1999/45/EC) Symbol & Indication Not required
R-Phrase Not required S-Phrase Not required Special markings Not required Hazardous ingredients for labeling None
Canada Information
This product is not a WHMIS-controlled product, since we consider it as a Manufactured article.
Section 16. Other Information
To the best of our knowledge, the information contained herein is accurate. However, we cannot assume any liability
whatsoever for the accuracy or completeness of the information contained herein.
<Reference>(1) Pulmonary Response to Toner upon Chronic Inhalation Exposure in Rats H. Muhle et. al Fundamental and Applied Toxicology 17.280-299(1991)Lung Clearance and Retention of Toner, Utilizing a Tracer Technique, during Chronic Inhalation Exposure in Rats B Bellmann Fundamental and Applied Toxicology 17.300-313(1(2) ACGIH TLV (Threshold Limit Values)(3) OSHA PEL (Permissible Exposure Limits)(4) IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol.93.(5) NIOSH CURRENT INTELLIGENCE BULLETIN "Evaluation of Health Hazard and Recommendation for Occupational Exposure to Titanium Dioxide DRAFT".*ISO 11014-1 Safety data sheet for chemical products.
<Abbreviation> ACGIH American Conference of Governmental Industrial Hygienists OSHA Occupational Safety and Health Administration TWA Time Weighted Average IARC International Agency for Research on Cancer EPA Environmental Protection Agency (USA) NTP National Toxicology Program MAK Maximale Arbeitsplatzkonzentrationen under Deutsche Forschungsgemeinschaft Proposition 65:California Safe Drinking Water and Toxic Enforcement Act of 1986. TRGS905 Technische Regeln für Gefahrstoffe (Deutsche) UN United Nations TSCA Toxic Substances Control Act (USA) WHMIS Workplace Hazardous Materials Information System(Canada)
End of MSDS
Page 1
SAFETY DATA SHEET
Section 1. Chemical Product and Company Identification
Product Name Yellow Toner For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci
Manufacturer KYOCERA Document Solutions Inc.
Address KYOCERA Document Solutions America, Inc.
225 Sand Road
Fairfield, NJ 07004
Telephone Number (973)-808-8444
Date April 01, 2015
Section 2. Composition/Information on Ingredients
Hazardous Components
(Chemical Identity, Common Name/s )SubpartZ ACGIH TLV IARC NTP Weight%
(CAS No. 66402-68-4)Ferrite (Ferrite including manganese)0.2mg/m3**Not Listed Not Listed 1-10***
(CAS No. 7631-86-9)Amorphous silica Not Listed Group3 Not Listed 1-5
(CAS No. 13463-67-7)Titanium dioxide 10mg/m3(TWA)Group 2B Not Listed <1
(Non Hazardous Ingredients)
Polyester resin (2 kinds)70-85
*(Ceiling)(Manganese compounds(asMn))
**(TWA)(Manganese and inorganic compounds as Mn)
***(as Mn:<2)
Section 3. Hazards Identification
Most Important Hazards None
Specific Hazards None
Other Information on Hazards: Potential Health Effects:
Ingestion Ingestion is not applicable route of entry for intended use.
Inhalation Prolonged inhalation of excessive dusts may cause lung damage.
Use of this product, as intended, does not result in inhalation of excessive dusts.
Eye Contact May cause transient eye irritation.
Skin Contact Unlikely to cause skin irritation.
OSHA PEL
80mg/m3/%SiO2(TWA)
5mg/m3*
15mg/m3
Yellow Toner For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 2 of 4 4/01/2015
SAFETY DATA SHEET
Section 4. First Aid Measures
Inhalation Remove from exposure to fresh air and gargle with plenty of water.
Seek medical treatment in case of such a symptom as coughing.
Skin Contact Wash with soap and water. If irritation does occur, seek medical treatment.
Eye Contact Flush thoroughly with water and seek medical treatment if irritating.
Ingestion Ingestion is not applicable route of entry for intended use.
Rinse out mouth. Drink one or two glasses of water to dilute.
Seek medical treatment if necessary.
Section 5. Fire Fighting Measures
Extinguishing Media Water (Sprinkle with water), Foam, Powder, CO2 or Dry Chemical Extinguisher.
Fire Fighting Procedure Pay attention not to blow away toner powder. Drain water off around and decrease
the atmosphere temperature to extinguish the fire.
Section 6. Accidental Release Measures
Personal Precautions Avoid inhalation, ingestion, eye and skin contact in case of accidental toner release.
Environmental Precautions Do not release into drains and surface water.
Method for Cleaning Up Gather the released toner, not blowing away, and wipe up with a wet cloth.
Section 7. Handling and Storage
Handling Keep the container tightly closed.
Keep away from children.
Storage Keep the container tightly closed and store in a cool, dry and dark place keeping
away from fire. Keep away from children.
Section 8. Exposure Controls/Personal Protection
Control Parameters<Reference Data>
ACGIH TLV(2)-TWA Inhalable fraction 10mg/m3, Respirable fraction 3mg/m3
OSHA PEL(3)-TWA Total dust 15mg/m3, Respirable fraction 5mg/m3
Protective Equipment
Respiratory Protection None required under normal use.
Eye/Face Protection None required under normal use.
Skin/Hand/Body Protection None required under normal use.
Ventilation Ventilator is not required under normal use.
Yellow Toner For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 3 of 4 4/01/2015
SAFETY DATA SHEET
Section 9. Physical and Chemical Properties
Appearance
Physical state Solid
Form Fine powder
Color Yellow
Odor Odorless
pH Not applicable
Melting Point 100-1200C[Toner]
Explosion Properties Dust explosion is improbable under normal use. Experimental explosiveness of toner
is classified into the same rank such kind of powder as flour, dry milk and resin powder
according to the pressure rising speed.
Density 1.2-1.4g/cm3[Toner]
Solubility Almost insoluble in water.
Section 10. Stability and Reactivity
Stability/Reactivity Stable under normal use.
Hazardous Decomposition Products None
Section 11. Toxicological Information
Acute oral toxicity (rat)LD50>2,000mg/kg (Estimated from other products containing same materials.)[Toner]
(rat)LD50>2,500mg/kg (Estimated from the data of constituent materials.)[Carrier]
Acute dermal toxicity (rat)LD50>2,000mg/kg (Estimated from Acute oral toxicity for same product.)[Toner]
(rat)LD50>2,000mg/kg (Estimated from the data of constituent materials.)[Carrier]
Acute inhalation toxicity (rat)LC50(4hr)>5.0mg/l (Estimated from other products containing same materials.)[Toner]
Acute eye irritation (rabbit) Minimal irritant (Estimated from other products containing same materials.)[Toner]
Acute skin irritation (rabbit) Non-irritant (Estimated from other products containing same materials.)[Toner]
(rabbit) Non-irritant (Estimated from the data of constituent materials.)[Carrier]
Skin sensitization (mouse)Non-Sensitiser (Estimated from other products containing same materials.)[Toner]
(guinea pig)Non-Sensitiser (Estimated from the data of constituent materials.)[Carrier]
Mutagenicity Ames Test is Negative.[Toner]
Ames Test is Negative. (Estimated from the data of constituent materials.)[Carrier]
Information of Ingredients: No mutagen, according to MAK, TRGS905 and (EC)No 1272/2008
AnnexVI Table3.2.Reproductive Toxicity
Information of Ingredients: No reproductive toxicant, according to MAK, California Proposition 65, TRGS905 and (EC)No 1272/2008
AnnexVI Table3.2.
Carcinogenicity
Information of Ingredients: No carcinogen or potential carcinogen (except titanium dioxide) according to IARC, Japan Association
on Industrial Health, ACGIH, EPA, OSHA, NTP, MAK, California Proposition 65, TRGS905, and (EC)No 1272/2008 AnnexVI Table3.2.
The IARC reevaluated titanium dioxide as a Group 2B carcinogen (possibly carcinogenic to humans) as the result of inhalation exposure test in rats. But, oral/skin test does not show carcinogenicity. (4) In the animal chronic inhalation studies for titanium dioxide, the lung
tumor was observed in only rats. It is estimated that this is attributed to the overload of the rat's lung clearance mechanism (overload phenomenon).(5)
The inhalation of excessive titanium dioxide does not occur in normal use of this product. Also, epidemiological studies to date have not revealed any evidence of the relation between occupational exposure to titanium dioxide and respiratory tract diseases.
Chronic effects: In a study in rats by chronic inhalation exposure to a typical toner, a mild to moderate degree of lung fibrosis was observed in 92% of the rats
in the high concentration (16mg/m3) exposure group, and a minimal to mild degree of fibrosis was noted in 22% of the animal in the middle
(4mg/m3) exposure group.(1) But no pulmonary change was reported in the lowest (1mg/m3) exposure group, the most relevant level to
potential human exposures.
Other Information: None
Yellow Toner For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 4 of 4 4/01/2015
SAFETY DATA SHEET
Section 12. Ecological Information
No data available.
Section 13. Disposal Considerations
Do not incinerate toner and toner containers. Dangerous sparks may cause burn.
Any disposal practice should be done under conditions which meet local, state and federal laws
and regulations relating to waste (contact local or state environmental agency for specific rules).
Section 14. Transport Information
UN No.None
UN Shipping Name None
UN Classification None
UN Packing Group None
Special Precautions None
Section 15. Regulatory Information
US Information
All components in this product comply with order under TSCA.
EU Information Label information according to the Directives 67/548/EEC and 1999/45/EC)
Symbol & Indication Not required
R-Phrase Not required
S-Phrase Not required
Special markings Not required
Hazardous ingredients for labeling None
Canada Information
This product is not a WHMIS-controlled product, since we consider it as a Manufactured article.
Section 16. Other Information
To the best of our knowledge, the information contained herein is accurate. However, we cannot assume any liability
whatsoever for the accuracy or completeness of the information contained herein.
<Reference>(1) Pulmonary Response to Toner upon Chronic Inhalation Exposure in Rats H. Muhle et. al Fundamental and Applied Toxicology 17.280-299(1991)Lung Clearance and Retention of Toner, Utilizing a Tracer Technique, during Chronic Inhalation Exposure in Rats B Bellmann Fundamental and Applied Toxicology 17.300-313(1991)
(2) ACGIH TLV (Threshold Limit Values)(3) OSHA PEL (Permissible Exposure Limits)(4) IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol.93.(5) NIOSH CURRENT INTELLIGENCE BULLETIN "Evaluation of Health Hazard and Recommendation for Occupational Exposure to Titanium Dioxide DRAFT".*ISO 11014-1 Safety data sheet for chemical products.
<Abbreviation> ACGIH American Conference of Governmental Industrial Hygienists OSHA Occupational Safety and Health Administration TWA Time Weighted Average IARC International Agency for Research on Cancer EPA Environmental Protection Agency (USA) NTP National Toxicology Program
MAK Maximale Arbeitsplatzkonzentrationen under Deutsche Forschungsgemeinschaft Proposition 65:California Safe Drinking Water and Toxic Enforcement Act of 1986. TRGS905 Technische Regeln für Gefahrstoffe (Deutsche) UN United Nations TSCA Toxic Substances Control Act (USA) WHMIS Workplace Hazardous Materials Information System(Canada)
End of MSDS
Page 1
SAFETY DATA SHEET
Section 1. Chemical Product and Company Identification
Product Name Black Developer For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci
Manufacturer KYOCERA Document Solutions Inc.
Address KYOCERA Document Solutions America, Inc.
225 Sand Road
Fairfield, NJ 07004
Telephone Number (973)-808-8444
Date April 01, 2015
Section 2. Composition/Information on Ingredients
Hazardous Components
(Chemical Identity, Common Name/s )SubpartZ ACGIH TLV IARC NTP Weight%
(CAS No. 66402-68-4)Ferrite (Ferrite including manganese)0.2mg/m3**Not Listed Not Listed 85-95***
(CAS No. 1333-86-4)Carbon Black 3.5mg/m3(TWA)Group2B Not Listed <1
(Non Hazardous Ingredients)
Polyester resin 5-10
*(Ceiling)(Manganese compounds(asMn))
**(TWA)(Manganese and inorganic compounds as Mn)
***(as Mn:85-95)
Section 3. Hazards Identification
Most Important Hazards None
Specific Hazards None
Other Information on Hazards: Potential Health Effects:
Ingestion Ingestion is not applicable route of entry for intended use.
Inhalation Prolonged inhalation of excessive dusts may cause lung damage.
Use of this product, as intended, does not result in inhalation of excessive dusts.
Eye Contact May cause transient eye irritation.
Skin Contact Unlikely to cause skin irritation.
OSHA PEL
5mg/m3*
3.5mg/m3 (TWA)
Black Developer For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 2 of 4 4/01/2015
SAFETY DATA SHEET
Section 4. First Aid Measures
Inhalation Remove from exposure to fresh air and gargle with plenty of water.
Seek medical treatment in case of such a symptom as coughing.
Skin Contact Wash with soap and water. If irritation does occur, seek medical treatment.
Eye Contact Do not rub eyes. Flush thoroughly with water and seek medical treatment if irritating.
Ingestion Ingestion is not applicable route of entry for intended use.
Rinse out mouth. Drink one or two glasses of water to dilute.
Seek medical treatment if necessary.
Section 5. Fire Fighting Measures
Extinguishing Media Water (Sprinkle with Water), Foam, Powder, CO2 or Dry Chemical Extinguisher.
Fire Fighting Procedures Pay attention not to blow away developer powder. Drain water off around and
decrease atmosphere temperature to extinguish the fire.
Section 6. Accidental Release Measures
Personal Precautions Avoid inhalation, ingestion, eye and skin contact in case of accidental developer release.
Environmental Precautions Do not release into drains and surface water.
Method for Cleaning Up Gather the released developer, not blowing away, and wipe up with a wet cloth.
Section 7. Handling and Storage
Handling Keep the container tightly closed.
Keep away from children.
Storage Keep the container tightly closed and store in a cool, dry and dark place keeping
away from fire. Keep away from children.
Section 8. Exposure Controls/Personal Protection
Control Parameters<Reference Data>
ACGIH TLV(2)-TWA Inhalable fraction 10mg/m3, Respirable fraction 3mg/m3
OSHA PEL(3)-TWA Total dust 15mg/m3, Respirable fraction 5mg/m3
Protective Equipment
Respiratory Protection None required under normal use.
Eye/Face Protection None required under normal use.
Skin/Hand/Body Protection None required under normal use.
Ventilation Ventilator is not required under normal use.
Black Developer For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 3 of 4 4/01/2015
SAFETY DATA SHEET
Section 9. Physical and Chemical Properties
Appearance
Physical state Solid
Form Fine powder
Color Black
Odor Odorless
pH Not applicable
Melting Point No data available
Explosion Properties Dust explosion is improbable under normal use. Experimental explosiveness of toner
is classified into the same rank such kind of powder as flour, dry milk and resin powder
according to the pressure rising speed.
Density 3.5-5.0 g/cm3
Solubility Almost insoluble in water.
Section 10. Stability and Reactivity
Stability/Reactivity Stable under normal use.
Hazardous Decomposition Products None
Section 11. Toxicological Information
Acute oral toxicity (rat)LD50>2,000mg/kg (Estimated from other products containing same materials.)[Toner]
(rat)LD50>2,500mg/kg (Estimated from the data of constituent materials.)[Carrier]
Acute dermal toxicity (rat)LD50>2,000mg/kg (Estimated from Acute oral toxicity for same product.)[Toner]
(rat)LD50>2,000mg/kg (Estimated from the data of constituent materials.)[Carrier]
Acute inhalation toxicity (rat)LC50(4hr)>5.0mg/l (Estimated from other products containing same materials.)[Toner]
Acute eye irritation (rabbit) Minimal irritant (Estimated from other products containing same materials.)[Toner]
Acute skin irritation (rabbit) Non-irritant (Estimated from other products containing same materials.)[Toner]
(rabbit) Non-irritant (Estimated from the data of constituent materials.)[Carrier]
Skin sensitization (mouse)Non-Sensitiser (Estimated from other products containing same materials.)[Toner]
(guinea pig)Non-Sensitiser (Estimated from the data of constituent materials.)[Carrier]
Mutagenicity Ames Test is Negative.[Toner]
Ames Test is Negative. (Estimated from the data of constituent materials.)[Carrier]
Information of Ingredients No mutagen, according to MAK, TRGS905 and (EC)No 1272/2008; AnnexVI Table 3.2.
Reproductive Toxicity
Information of Ingredients No reproductive toxicant, according to MAK, California Proposition 65, TRGS905 and
(EC)No 1272/2008 AnnexVI Table3.2.
Carcinogenicity
Information of Ingredients No carcinogen or potential carcinogen (except carbon black) according to IARC, Japan
Association on Industrial Health, ACGIH, EPA, OSHA, NTP, MAK, California
Proposition 65, TRGS905 and (EC)No 1272/2008 AnnexVI Table3.2.
The IARC reevaluated carbon black as a Group 2B carcinogen (possibly carcinogenic to humans) as the result of inhalation exposure test in rats. But, oral/skin test
does not show carcinogenicity.(4) The evaluation of carbon black is based upon the development of lung tumors in rat receiving chronic inhalation exposures to free
carbon black at level that induce particle overload of the lung.
The studies performed in animal models other than rats have not demonstrated an association between carbon black and lung tumors. Moreover, a two-year's cancer
bioassay using a typical toner preparation containing carbon black demonstrated no association between toner exposure and tumor development in rats.(1)
Chronic effects
In a study in rats by chronic inhalation exposure to a typical toner, a mild to moderate degree of lung fibrosis was observed in 92% of the rats in the high concentration
(16mg/m3) exposure group, and a minimal to mild degree of fibrosis was noted in 22% of the animal in the middle (4mg/m3) exposure group.(1) But no pulmonary
change was reported in the lowest (1mg/m3) exposure group, the most relevant level to potential human exposures.
Other Information: None
Black Developer For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 4 of 4 4/01/2015
SAFETY DATA SHEET
Section 12. Ecological Information
No data available.
Section 13. Disposal Considerations
Do not incinerate developer and developer containers. Dangerous sparks may cause burn.
Any disposal practice should be done under conditions which meet local, state and federal laws
and regulations relating to waste (contact local or state environmental agency for specific rules).
Section 14. Transport Information
UN No.None
UN Shipping Name NoneUN Classification None
UN Packing Group None
Special Precautions None
Section 15. Regulatory Information
US InformationAll components in this product comply with order under TSCA.
Canada InformationThis product is not a WHMIS-controlled product, since we consider it as a Manufactured article.
EU Information Label information according to the Directives 67/548/EEC and 1999/45/EC) Symbol & Indication Not required R-Phrase Not required S-Phrase Not required Special markings Not required Hazardous ingredients for labeling None
Section 16. Other Information
To the best of our knowledge, the information contained herein is accurate. However, we cannot assume any liability
whatsoever for the accuracy or completeness of the information contained herein.
<Reference>(1) Pulmonary Response to Toner upon Chronic Inhalation Exposure in Rats H. Muhle et. al Fundamental and Applied Toxicology 17.280-299(1991)Lung Clearance and Retention of Toner, Utilizing a Tracer Technique, during Chronic Inhalation Exposure in Rats B Bellmann Fundamental and Applied Toxicology 17.300-313(1991)(2) ACGIH TLV (Threshold Limit Values)(3) OSHA PEL (Permissible Exposure Limits)(4) IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol.93.*ISO 11014-1 Safety data sheet for chemical products.
<Abbreviation> ACGIH American Conference of Governmental Industrial Hygienists OSHA Occupational Safety and Health Administration TWA Time Weighted Average IARC International Agency for Research on Cancer
EPA Environmental Protection Agency (USA) NTP National Toxicology Program MAK Maximale Arbeitsplatzkonzentrationen under Deutsche Forschungsgemeinschaft Proposition 65:California Safe Drinking Water and Toxic Enforcement Act of 1986. TRGS905 Technische Regeln für Gefahrstoffe (Deutsche) UN United Nations TSCA Toxic Substances Control Act (USA) WHMIS Workplace Hazardous Materials Information System(Canada)
End of MSDS
Page 1
SAFETY DATA SHEET
Section 1. Chemical Product and Company Identification
Product Name Cyan Developer For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci
Manufacturer KYOCERA Document Solutions Inc.
Address KYOCERA Document Solutions America, Inc.
225 Sand Road
Fairfield, NJ 07004
Telephone Number (973)-808-8444
Date April 01, 2015
Section 2. Composition/Information on Ingredients
Hazardous Components
(Chemical Identity, Common Name/s )SubpartZ ACGIH TLV IARC NTP Weight%
(CAS No. 66402-68-4)Ferrite (Ferrite including manganese)0.2mg/m3**Not Listed Not Listed 85-95***
(Non Hazardous Ingredients)
Polyester resin 5-10
*(Ceiling)(Manganese compounds(asMn))
**(TWA)(Manganese and inorganic compounds as Mn)
***(as Mn:85-95)
Section 3. Hazards Identification
Most Important Hazards None
Specific Hazards None
Other Information on Hazards: Potential Health Effects:
Potential Health Effects:
Ingestion Ingestion is not applicable route of entry for intended use.
Inhalation Prolonged inhalation of excessive dusts may cause lung damage.Use of this product, as intended, does not result in inhalation of excessive dusts.
Eye Contact May cause transient eye irritation.
Skin Contact Unlikely to cause skin irritation.
OSHA PEL
5mg/m3*
Cyan Developer For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 2 of 4 4/01/2015
SAFETY DATA SHEET
Section 4. First Aid Measures
Inhalation Remove from exposure to fresh air and gargle with plenty of water.
Seek medical treatment in case of such a symptom as coughing.
Skin Contact Wash with soap and water. If irritation does occur, seek medical treatment.
Eye Contact Do not rub eyes. Flush thoroughly with water and seek medical treatment if irritating.
Ingestion Ingestion is not applicable route of entry for intended use.
Rinse out mouth. Drink one or two glasses of water to dilute.
Seek medical treatment if necessary.
Section 5. Fire Fighting Measures
Extinguishing Media Water (Sprinkle with Water), Foam, Powder, CO2 or Dry Chemical Extinguisher.
Fire Fighting Procedures Pay attention not to blow away developer powder. Drain water off around and
decrease atmosphere temperature to extinguish the fire.
Section 6. Accidental Release Measures
Personal Precautions Avoid inhalation, ingestion, eye and skin contact in case of accidental developer
release.
Environmental Precautions Do not release into drains and surface water.
Method for Cleaning Up Gather the released developer, not blowing away, and wipe up with a wet cloth.
Section 7. Handling and Storage
Handling Keep the container tightly closed.
Keep away from children.
Storage Keep the container tightly closed and store in a cool, dry and dark place keeping
away from fire. Keep away from children.
Section 8. Exposure Controls/Personal Protection
Control Parameters<Reference Data>
ACGIH TLV(2)-TWA Inhalable fraction 10mg/m3, Respirable fraction 3mg/m3
OSHA PEL(3)-TWA Total dust 15mg/m3, Respirable fraction 5mg/m3
Protective Equipment
Respiratory Protection None required under normal use.
Eye/Face Protection None required under normal use.
Skin/Hand/Body Protection None required under normal use.
Ventilation None required under normal use.
Cyan Developer For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 3 of 4 4/01/2015
SAFETY DATA SHEET
Section 9. Physical and Chemical Properties
Appearance
Physical state Solid
Form Fine powder
Color Cyan
Odor Odorless
pH Not applicable
Melting Point No data available
Explosion Properties Dust explosion is improbable under normal use. Experimental explosiveness of toner
is classified into the same rank such kind of powder as flour, dry milk and resin powder
according to the pressure rising speed.
Density 3.5-5.0 g/cm3
Solubility Almost insoluble in water.
Section 10. Stability and Reactivity
Stability/Reactivity Stable under normal use.
Hazardous Decomposition Products None
Section 11. Toxicological Information
Acute oral toxicity (rat)LD50>2,000mg/kg(Estimated from other products containing same materials.)[Toner]
(rat)LD50>2,500mg/kg(Estimated from the data of constituent materials.)[Carrier]
Acute dermal toxicity (rat)LD50>2,000mg/kg(Estimated from Acute oral toxicity for same product.)[Toner]
(rat)LD50>2,000mg/kg(Estimated from the data of constituent materials.) [Carrier]
Acute inhalation toxicity (rat)LC50(4 hr)>5.0mg/l(Estimated from other products containing same materials.)[Toner]
Acute eye irritation (rabbit) Minimal irritant(Estimated from other products containing same materials.)[Toner]
Acute skin irritation (rabbit) Non irritant(Estimated from other products containing same materials.)[Toner]
(rabbit) Non irritant(Estimated from the data of constituent materials.) [Carrier]
Skin sensitization (mouse)Non-Sensitizer(Estimated from other products containing same materials.)[Toner]
(guinea pig)Non-Sensitizer(Estimated from the data of constituent materials.)[Carrier]
Mutagenicity Ames Test is Negative. [Toner]
Ames Test is Negative.
(Estimated from the data of constituent materials.)[Carrier]
Information of Ingredients No mutagen, according to MAK, TRGS905 and (EC)No 1272/2008; AnnexVI Table 3.2.
Reproductive Toxicity
Information of Ingredients No reproductive toxicant, according to MAK, California Proposition 65, TRGS905 and
(EC)No 1272/2008 AnnexVI Table3.2.
Carcinogenicity
Information of Ingredients No carcinogen or potential carcinogen according to IARC, Japan
Association on Industrial Health, ACGIH, EPA, OSHA, NTP, MAK, California
Proposition 65, TRGS905 and (EC)No 1272/2008 AnnexVI Table3.2.
Chronic effects
In a study in rats by chronic inhalation exposure to a typical toner, a mild to moderate degree of lung fibrosis was observed in 92% of the rats in the high concentration
(16mg/m3) exposure group, and a minimal to mild degree of fibrosis was noted in 22% of the animal in the middle (4mg/m3) exposure group.(1) But no pulmonary
change was reported in the lowest (1mg/m3) exposure group, the most relevant level to potential human exposures.
Other Information: None
Cyan Developer For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 4 of 4 4/01/2015
SAFETY DATA SHEET
Section 12. Ecological Information
No data available.
Section 13. Disposal Considerations
Do not incinerate developer and developer containers. Dangerous sparks may cause burn.
Any disposal practice should be done under conditions which meet local, state and federal laws
and regulations relating to waste (contact local or state environmental agency for specific rules).
Section 14. Transport Information
UN No.None
UN Shipping Name None
UN Classification None
UN Packing Group None
Special Precautions None
Section 15. Regulatory Information
US Information
All components in this product comply with order under TSCA.
Canada Information
This product is not a WHMIS-controlled product, since we consider it as a Manufactured article.
EU Information Label information according to the Directives 67/548/EEC and 1999/45/EC)
Symbol & Indication Not required
R-Phrase Not required
S-Phrase Not required
Special markings Not required
Hazardous ingredients for labeling None
Section 16. Other Information
To the best of our knowledge, the information contained herein is accurate. However, we cannot assume any liability
whatsoever for the accuracy or completeness of the information contained herein.
<Reference>(1) Pulmonary Response to Toner upon Chronic Inhalation Exposure in Rats H. Muhle et. al Fundamental and Applied Toxicology 17.280-299(1991)
Lung Clearance and Retention of Toner, Utilizing a Tracer Technique, during Chronic Inhalation Exposure in Rats B Bellmann Fundamental and Applied Toxicology 17.300-313(1991)(2) ACGIH TLV (Threshold Limit Values)(3) OSHA PEL (Permissible Exposure Limits)*ISO 11014-1 Safety data sheet for chemical products.
<Abbreviation> ACGIH American Conference of Governmental Industrial Hygienists OSHA Occupational Safety and Health Administration TWA Time Weighted Average
IARC International Agency for Research on Cancer EPA Environmental Protection Agency (USA) NTP National Toxicology Program MAK Maximale Arbeitsplatzkonzentrationen under Deutsche Forschungsgemeinschaft Proposition 65:California Safe Drinking Water and Toxic Enforcement Act of 1986. TRGS905 Technische Regeln für Gefahrstoffe (Deutsche) UN United Nations TSCA Toxic Substances Control Act (USA) WHMIS Workplace Hazardous Materials Information System(Canada)
End of MSDS
Page 1
SAFETY DATA SHEET
Section 1. Chemical Product and Company Identification
Product Name Magenta Developer For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci
Manufacturer KYOCERA Document Solutions Inc.
Address KYOCERA Document Solutions America, Inc.
225 Sand Road
Fairfield, NJ 07004
Telephone Number (973)-808-8444
Date April 01, 2015
Section 2. Composition/Information on Ingredients
Hazardous Components
(Chemical Identity, Common Name/s )SubpartZ ACGIH TLV IARC NTP Weight%
(CAS No. 66402-68-4)Ferrite (Ferrite including manganese)0.2mg/m3**Not Listed Not Listed 85-95***
(Non Hazardous Ingredients)
Polyester resin 5-10
*(Ceiling)(Manganese compounds(asMn))
**(TWA)(Manganese and inorganic compounds as Mn)
***(as Mn:85-95)
Section 3. Hazards Identification
Most Important Hazards None
Specific Hazards None
Other Information on Hazards: Potential Health Effects:
Ingestion Ingestion is not applicable route of entry for intended use.
Inhalation Prolonged inhalation of excessive dusts may cause lung damage.
Use of this product, as intended, does not result in inhalation of excessive dusts.
Eye Contact May cause transient eye irritation.
Skin Contact Unlikely to cause skin irritation.
5mg/m3*
OSHA PEL
Magenta Developer For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 2 of 4 4/01/2015
SAFETY DATA SHEET
Section 4. First Aid Measures
Inhalation Remove from exposure to fresh air and gargle with plenty of water.
Seek medical treatment in case of such a symptom as coughing.
Skin Contact Wash with soap and water. If irritation does occur, seek medical treatment.
Eye Contact Do not rub eyes. Flush thoroughly with water and seek medical treatment if irritating.
Ingestion Ingestion is not applicable route of entry for intended use.
Rinse out mouth. Drink one or two glasses of water to dilute.
Seek medical treatment if necessary.
Section 5. Fire Fighting Measures
Extinguishing Media Water (Sprinkle with Water), Foam, Powder, CO2 or Dry Chemical Extinguisher.
Fire Fighting Procedures Pay attention not to blow away developer powder. Drain water off around and
decrease atmosphere temperature to extinguish the fire.
Section 6. Accidental Release Measures
Personal Precautions Avoid inhalation, ingestion, eye and skin contact in case of accidental developer
release.
Environmental Precautions Do not release into drains and surface water.
Method for Cleaning Up Gather the released developer, not blowing away, and wipe up with a wet cloth.
Section 7. Handling and Storage
Handling Keep the container tightly closed.
Keep away from children.
Storage Keep the container tightly closed and store in a cool, dry and dark place keeping
away from fire. Keep away from children.
Section 8. Exposure Controls/Personal Protection
Control Parameters<Reference Data>
ACGIH TLV(2)-TWA Inhalable fraction 10mg/m3, Respirable fraction 3mg/m3
OSHA PEL(3)-TWA Total dust 15mg/m3, Respirable fraction 5mg/m3
Protective Equipment
Respiratory Protection None required under normal use.
Eye/Face Protection None required under normal use.
Skin/Hand/Body Protection None required under normal use.
Ventilation None required under normal use.
Magenta Developer For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 3 of 4 4/01/2015
SAFETY DATA SHEET
Section 9. Physical and Chemical Properties
Appearance
Physical state Solid
Form Fine powder Color Magenta Odor Odorless
pH Not applicable
Melting Point No data available
Explosion Properties Dust explosion is improbable under normal use. Experimental explosiveness of toneris classified into the same rank such kind of powder as flour, dry milk and resin powder
according to the pressure rising speed.
Density 3.5-5.0 g/cm3
Solubility Almost insoluble in water.
Section 10. Stability and Reactivity
Stability/Reactivity Stable under normal use.
Hazardous Decomposition Products None
Section 11. Toxicological Information
Acute oral toxicity (rat)LD50>2,000mg/kg(Estimated from other products containing same materials.)[Toner]
(rat)LD50>2,500mg/kg(Estimated from the data of constituent materials.)[Carrier]
Acute dermal toxicity (rat)LD50>2,000mg/kg(Estimated from Acute oral toxicity for same product.)[Toner]
(rat)LD50>2,000mg/kg(Estimated from the data of constituent materials.)[Carrier]
Acute inhalation toxicity (rat)LC50(4 hr)>5.0mg/l(Estimated from other products containing same materials.)[Toner]
Acute eye irritation (rabbit) Minimal irritant(Estimated from other products containing same materials.)[Toner]
Acute skin irritation (rabbit) Non irritant(Estimated from other products containing same materials.)[Toner]
(rabbit) Non irritant(Estimated from the data of constituent materials.) [Carrier]
Skin sensitization (mouse)Non-Sensitizer(Estimated from other products containing same materials.)[Toner]
(guinea pig)Non-Sensitizer(Estimated from the data of constituent materials.)[Carrier]
Mutagenicity Ames Test is Negative. [Toner]
Ames Test is Negative.
(Estimated from the data of constituent materials.)[Carrier]
Information of Ingredients No mutagen, according to MAK, TRGS905 and (EC)No 1272/2008; AnnexVI Table 3.2.
Reproductive Toxicity
Information of Ingredients No reproductive toxicant, according to MAK, California Proposition 65, TRGS905 and
(EC)No 1272/2008 AnnexVI Table3.2.
Carcinogenicity
Information of Ingredients No carcinogen or potential carcinogen according to IARC, Japan Association on Industrial Health, ACGIH, EPA, OSHA, NTP, MAK, California Proposition 65, TRGS905 and (EC)No 1272/2008 AnnexVI Table3.2.
Chronic effects
In a study in rats by chronic inhalation exposure to a typical toner, a mild to moderate degree of lung fibrosis was observed in 92% of the rats in the high concentration
(16mg/m3) exposure group, and a minimal to mild degree of fibrosis was noted in 22% of the animal in the middle (4mg/m3) exposure group.(1) But no pulmonary
change was reported in the lowest (1mg/m3) exposure group, the most relevant level to potential human exposures.
Other Information: None
Magenta Toner For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 4 of 4 4/01/2015
SAFETY DATA SHEET
Section 12. Ecological Information
No data available.
Section 13. Disposal Considerations
Do not incinerate developer and developer containers. Dangerous sparks may cause burn.
Any disposal practice should be done under conditions which meet local, state and federal laws
and regulations relating to waste (contact local or state environmental agency for specific rules).
Section 14. Transport Information
UN No.None
UN Shipping Name None
UN Classification None
UN Packing Group None
Special Precautions None
Section 15. Regulatory Information
US Information
All components in this product comply with order under TSCA.
Canada Information
This product is not a WHMIS-controlled product, since we consider it as a Manufactured article.
EU Information Label information according to the Directives 67/548/EEC and 1999/45/EC)
Symbol & Indication Not required
R-Phrase Not required
S-Phrase Not required
Special markings Not required
Hazardous ingredients for labeling None
Section 16. Other Information
To the best of our knowledge, the information contained herein is accurate. However, we cannot assume any liability
whatsoever for the accuracy or completeness of the information contained herein.
<Reference>(1) Pulmonary Response to Toner upon Chronic Inhalation Exposure in Rats H. Muhle et. al Fundamental and Applied Toxicology 17.280-299(1991)Lung Clearance and Retention of Toner, Utilizing a Tracer Technique, during Chronic Inhalation Exposure in Rats B Bellmann Fundamental and Applied Toxicology 17.300-313(1991)(2) ACGIH TLV (Threshold Limit Values)
(3) OSHA PEL (Permissible Exposure Limits)*ISO 11014-1 Safety data sheet for chemical products.
<Abbreviation> ACGIH American Conference of Governmental Industrial Hygienists OSHA Occupational Safety and Health Administration TWA Time Weighted Average IARC International Agency for Research on Cancer EPA Environmental Protection Agency (USA) NTP National Toxicology Program MAK Maximale Arbeitsplatzkonzentrationen under Deutsche Forschungsgemeinschaft Proposition 65:California Safe Drinking Water and Toxic Enforcement Act of 1986. TRGS905 Technische Regeln für Gefahrstoffe (Deutsche) UN United Nations TSCA Toxic Substances Control Act (USA) WHMIS Workplace Hazardous Materials Information System(Canada)
End of MSDS
Page 1
SAFETY DATA SHEET
Section 1. Chemical Product and Company Identification
Product Name Yellow Developer For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci
Manufacturer KYOCERA Document Solutions Inc.
Address KYOCERA Document Solutions America, Inc.
225 Sand Road
Fairfield, NJ 07004
Telephone Number (973)-808-8444
Date April 01, 2015
Section 2. Composition/Information on Ingredients
Hazardous Components
(Chemical Identity, Common Name/s )SubpartZ ACGIH TLV IARC NTP Weight%
(CAS No. 66402-68-4)Ferrite (Ferrite including manganese)0.2mg/m3**Not Listed Not Listed 85-95***
(Non Hazardous Ingredients)
Polyester resin 5-10
*(Ceiling)(Manganese compounds(asMn))
**(TWA)(Manganese and inorganic compounds as Mn)
***(as Mn:85-95)
Section 3. Hazards Identification
Most Important Hazards None
Specific Hazards None
Other Information on Hazards: Potential Health Effects:
Ingestion Ingestion is not applicable route of entry for intended use.
Inhalation Prolonged inhalation of excessive dusts may cause lung damage.Use of this product, as intended, does not result in inhalation of excessive dusts.
Eye Contact May cause transient eye irritation.
Skin Contact Unlikely to cause skin irritation.
5mg/m3*
OSHA PEL
Yellow Developer For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 2 of 4 4/01/2015
SAFETY DATA SHEET
Section 4. First Aid Measures
Inhalation Remove from exposure to fresh air and gargle with plenty of water.
Seek medical treatment in case of such a symptom as coughing.
Skin Contact Wash with soap and water. If irritation does occur, seek medical treatment.
Eye Contact Do not rub eyes. Flush thoroughly with water and seek medical treatment if irritating.
Ingestion Ingestion is not applicable route of entry for intended use.
Rinse out mouth. Drink one or two glasses of water to dilute.
Seek medical treatment if necessary.
Section 5. Fire Fighting Measures
Extinguishing Media Water (Sprinkle with Water), Foam, Powder, CO2 or Dry Chemical Extinguisher.
Fire Fighting Procedure Pay attention not to blow away developer powder. Drain water off around and
decrease atmosphere temperature to extinguish the fire.
Section 6. Accidental Release Measures
Personal Precautions Avoid inhalation, ingestion, eye and skin contact in case of accidental developer
release.
Environmental Precautions Do not release into drains and surface water.
Method for Cleaning Up Gather the released developer, not blowing away, and wipe up with a wet cloth.
Section 7. Handling and Storage
Handling Keep the container tightly closed.
Keep away from children.
Storage Keep the container tightly closed and store in a cool, dry and dark place keeping
away from fire. Keep away from children.
Section 8. Exposure Controls/Personal Protection
Control Parameters<Reference Data>
ACGIH TLV(2)-TWA Inhalable fraction 10mg/m3, Respirable fraction 3mg/m3
OSHA PEL(3)-TWA Total dust 15mg/m3, Respirable fraction 5mg/m3
Protective Equipment
Respiratory Protection None required under normal use.
Eye/Face Protection None required under normal use.
Skin/Hand/Body Protection None required under normal use.
Ventilation None required under normal use.
Yellow Developer For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 3 of 4 4/01/2015
SAFETY DATA SHEET
Section 9. Physical and Chemical Properties
Appearance
Physical state Solid Form Fine powder
Color Yellow Odor Odorless
pH Not applicable
Melting Point No data available
Explosion Properties Dust explosion is improbable under normal use. Experimental explosiveness of toneris classified into the same rank such kind of powder as flour, dry milk and resin powderaccording to the pressure rising speed.
Density 3.5-5.0g/cm3
Solubility Almost insoluble in water.
Section 10. Stability and Reactivity
Stability/Reactivity Stable under normal use.
Hazardous Decomposition Products None
Section 11. Toxicological Information
Acute oral toxicity (rat)LD50>2,000mg/kg(Estimated from other products containing same materials.)[Toner]
(rat)LD50>2,500mg/kg(Estimated from the data of constituent materials.)[Carrier]
Acute dermal toxicity (rat)LD50>2,000mg/kg(Estimated from Acute oral toxicity for same product.)[Toner]
(rat)LD50>2,000mg/kg(Estimated from the data of constituent materials.)[Carrier]
Acute inhalation toxicity (rat)LC50(4 hr)>5.0mg/l(Estimated from other products containing same materials.)[Toner]
Acute eye irritation (rabbit) Minimal irritant(Estimated from other products containing same materials.)[Toner]
Acute skin irritation (rabbit) Non irritant(Estimated from other products containing same materials.)[Toner]
(rabbit) Non irritant(Estimated from the data of constituent materials.) [Carrier]
Skin sensitization (mouse)Non-Sensitizer(Estimated from other products containing same materials.)[Toner]
(guinea pig)Non-Sensitizer(Estimated from the data of constituent materials.)[Carrier]
Mutagenicity Ames Test is Negative. [Toner]
Ames Test is Negative.
(Estimated from the data of constituent materials.)[Carrier]
Information of Ingredients No mutagen, according to MAK, TRGS905 and (EC)No 1272/2008; AnnexVI Table 3.2.
Reproductive Toxicity
Information of Ingredients No reproductive toxicant, according to MAK, California Proposition 65, TRGS905 and
(EC)No 1272/2008 AnnexVI Table3.2.
Carcinogenicity
Information of Ingredients No carcinogen or potential carcinogen according to IARC, Japan
Association on Industrial Health, ACGIH, EPA, OSHA, NTP, MAK, California
Proposition 65, TRGS905 and (EC)No 1272/2008 AnnexVI Table3.2.
Chronic effects
In a study in rats by chronic inhalation exposure to a typical toner, a mild to moderate degree of lung fibrosis was observed in 92% of the rats in the high
concentration (16mg/m3) exposure group, and a minimal to mild degree of fibrosis was noted in 22% of the animal in the middle (4mg/m3) exposure group.(1)
But no pulmonary change was reported in the lowest (1mg/m3) exposure group, the most relevant level to potential human exposures.
Other Information: None
Yellow Developer For TASKalfa 4550ci, 4551ci, 5550ci, 5551ci Page 4 of 4 4/01/2015
SAFETY DATA SHEET
Section 12. Ecological Information
No data available.
Section 13. Disposal Considerations
Do not incinerate developer and developer containers. Dangerous sparks may cause burn.
Any disposal practice should be done under conditions which meet local, state and federal laws
and regulations relating to waste (contact local or state environmental agency for specific rules).
Section 14. Transport Information
UN No.NoneUN Shipping Name None
UN Classification None
UN Packing Group None
Special Precautions None
Section 15. Regulatory Information
US Information
All components in this product comply with order under TSCA.
Canada Information
This product is not a WHMIS-controlled product, since we consider it as a Manufactured article.
EU Information Label information according to the Directives 67/548/EEC and 1999/45/EC)
Symbol & Indication Not required
R-Phrase Not required
S-Phrase Not required
Special markings Not required
Hazardous ingredients for labeling None
Section 16. Other Information
To the best of our knowledge, the information contained herein is accurate. However, we cannot assume any liability
whatsoever for the accuracy or completeness of the information contained herein.
<Reference>(1) Pulmonary Response to Toner upon Chronic Inhalation Exposure in Rats H. Muhle et. al Fundamental and Applied Toxicology 17.280-299(1991)Lung Clearance and Retention of Toner, Utilizing a Tracer Technique, during Chronic Inhalation Exposure in Rats B Bellmann Fundamental and Applied Toxicology 17.300-313(1991)
(2) ACGIH TLV (Threshold Limit Values)(3) OSHA PEL (Permissible Exposure Limits)*ISO 11014-1 Safety data sheet for chemical products.
<Abbreviation> ACGIH American Conference of Governmental Industrial Hygienists OSHA Occupational Safety and Health Administration TWA Time Weighted Average IARC International Agency for Research on Cancer
EPA Environmental Protection Agency (USA) NTP National Toxicology Program MAK Maximale Arbeitsplatzkonzentrationen under Deutsche Forschungsgemeinschaft Proposition 65:California Safe Drinking Water and Toxic Enforcement Act of 1986. TRGS905 Technische Regeln für Gefahrstoffe (Deutsche) UN United Nations TSCA Toxic Substances Control Act (USA) WHMIS Workplace Hazardous Materials Information System(Canada)
End of MSDS